-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Blueprint Medicines Corp quarterly/annual Nonoperating Income (Expense) history and growth rate from 2013 to 2023.
- Blueprint Medicines Corp Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$6.85M, a 48.1% decline year-over-year.
- Blueprint Medicines Corp Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $151M.
- Blueprint Medicines Corp annual Nonoperating Income (Expense) for 2023 was -$19.7M, a 33.7% decline from 2022.
- Blueprint Medicines Corp annual Nonoperating Income (Expense) for 2022 was -$14.8M, a 1746% decline from 2021.
- Blueprint Medicines Corp annual Nonoperating Income (Expense) for 2021 was $897K, a 85.6% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)